搜索结果
疾病ID:TCMBANKDI029936
疾病名:Gingival Overgrowth
MeSH_Name:Stomatognathic Diseases
HPO_Name:Abnormality of head or neck
UMLS_Name:Finding
DO_Name:disease of anatomical entity
疾病类型:phenotype
DisGeNET_Link:C0376480
MeSH_Link:C07
HPO_Link:HP:0000152
UMLS_Link:T033
DO_Link:DOID:7
HERB_ID:HBDIS008567
疾病对应的植物
| ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
|---|
疾病对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN061570 | curcumin | (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one; C10443; BSPBio_003590; NCGC00095321-01; Curcumin; KBio3_003004; InChI=1/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-13,22,24-25H,1-2H3/b7-3+,8-4+,16-13; curcumin ; diferuloylmethane; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,4,6-trien-3-one; Kacha haldi; (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one; ZINC00899824; 458-37-7; SDCCGMLS-0066836.P001; SCHEMBL2622435; Spectrum3_001990; DivK1c_006683; KBio1_001627; SpecPlus_000587; SPBio_001728; Spectrum2_001714; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one; NSC32982; Turmeric oleoresin (79%-85% curcumin); Yellow Root; Halad; Diferaloylmethane; kachs haldi; safra d'inde; Curcumin, 95% (total curcuminoid content), from Turmeric rhizome; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; GTPL7000; Turmeric, oleoresin; CI 75300; MFCD00008365; curcuma longa l. root oil hydrodistilled; DSSTox_CID_1421; NSC-687842; C21H20O6; Merita earth; NCGC00017159-11; 1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; NCGC00017159-06; I06-2497; BDBM50140172; I14-19358; MLS001148449; LS-125; NCGC00023332-04; SCHEMBL8441; 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one; BIDD:ER0479; 458-37-7; Turmeric root oil; Tox21_111505; BDBM50067040; 1790-EP2308861A1; Safran d'Inde; Turmeric oil (Curcuma longa L.); NSC 687842; Tumeric yellow; NCGC00017159-05; Curcuma oil; (1E,6E)-1,7-bis[4-hydroxy-3-(methyloxy)phenyl]hepta-1,6-diene-3,5-dione; 2,7-Nonadiene-4,6-dione, 1,9-bis(4-hydroxy-3-methoxyphenyl)-; EINECS 207-280-5; 15845-47-3; E 100; Curcuma longa l. oleoresin; Curcuma longa l. root oleoresin; SR-01000000149-2; NCGC00017159-10; D0H8LC; HMS3649K06; Turmeric oleoresin; Orange Root; Curcumin (Natural); Indian saffron; Curcumin, United States Pharmacopeia (USP) Reference Standard; NCGC00017159-07; CCG-36107; Curcumin solution, ~0.1 % (w/v) (in ethanol with 2M HCl (99:1 v/v)), for TLC derivatization; 5-Hydroxy-1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,4,6-trien-3-one; Curcurmin; 1,5-Di(vanillyliden)acetylaceton; I06-0010; Natural yellow 3; SMR000058237; cid_969516; Zlut prirodni 3; CHEMBL140; CAS-458-37-7; Curcumin, analytical standard; BG0601; ZX-AT003872; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione #; BCP9000557; Yellow puccoon; Tumeric oleoresin; DB11672; 1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione; BG00706978; NSC687842; AC1LJ6T6; SCHEMBL8440; SR-01000000149; Tox21_201116; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; J10108; C.I. Natural Yellow 3; (1E,4Z,6E)-5-Hydroxy-1,7-bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,4,6-trien-3-one; Curcumin (synthetic); BIC8500; NCGC00017159-09; CCRIS 5804; NCGC00023332-05; (1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione; W-5038; 1,7-DI(4-HYDROXY-3-METHOXYPHENYL)HEPTA-1,6-DIENE-3; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, (E,E)-; FEMA No. 3086; 1790-EP2305629A1; BB_NC-01422; BC678109; 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-; WLN: 1OR BQ E1U1V1V1U1R DQ CO1; Yellow Ginger; Diferuloylmethane; BRN 2306965; Bio-0677; AC1Q46A0; 98% curcurmin); cid_5281767; ZINC899824; Oils, galangal; 33171-04-9; (1E,6E)-1,7-bis(3-methoxy-4-oxidanyl-phenyl)hepta-1,6-diene-3,5-dione; curcuma longa l. root oil CO2 extract; Gelbwurz; OR24598; Oil of turmeric; Curcuma oil (Curcuma longa); MLS000069631; 1,5-Divanillyliden-2,4-pentandion; BDBM29532; 1,7-bis(4-hydroxy-3-methoxyphenyl)1,6-heptadiene-3,5-dione; UNII-IT942ZTH98; Yellow, Turmeric; BCP0726000035; Tox21_110803; KB-251224; CU-01000001305-2; Turmeric oil; HMS2233K04; D07SDQ; ST055629; Curcumin, primary pharmaceutical reference standard; CCG-36020; BRD-K07572174-001-19-6; MolPort-001-763-682; DSSTox_GSID_31077; DSSTox_RID_78861; Turmeric; 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-; NSC-32982; Kacha haldi; HY-N0005; Kurkumin [Czech]; Haldar; PREVENTION 4 (CURCUMIN) (SEE ALSO TUMERIC, OLEORESIN (10105-J)); (1Z,6E)-1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione; Turmeric (>98% curcurmin); GP8291; M212; Zlut prirodni 3 [Czech]; VFLDPWHFBUODDF-FCXRPNKRSA-N; LS-2189; Turmeric yellow; Turmeric extract (Curcuma longa L.); Curcumin; 1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; TR-032605; Curcuma longa l. root oil; FEMA No. 3085; curouma; Tu rmeric root oil; Opera_ID_1627; AC-24238; 73729-23-4; Halud; 1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione; RTR-032605; Yo-Kin; NCGC00023332-03; trans,trans-Curcumin; Curcuma longa l. oil; 1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (1E,6E)-; IT942ZTH98; (E,E)-1,7-bis(4-Hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; diferuloylmethan; cMAP_000052; N1839; 1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; BG01656528; Curcuma; CCRIS 3257; Diferulylmethane; Curcumin, >=94% (curcuminoid content), >=80% (Curcumin); NCGC00017159-04; SC-17381; BRD-K07572174-001-22-0; turmeric root oil hydrodistilled; Oils, curcuma; 458C377; Hydrastis; AK316302; Haldar, Souchet; Natural Yellow3; 4-08-00-03697 (Beilstein Handbook Reference); E 100 (Dye); 1,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-; CS-1490; Indian turmeric; (1E,6E)-1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-hepta-1,6-diene-3,5-dione; ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione); Kurkumin; Curcumin I; Souchet; (1E,6E)-1,7-bis(4-hydroxy-3-methoxy-phenyl)hepta-1,6-diene-3,5-dione; HSDB 4334; Haidr; NCI-C61325; BBL027711; Golden seal; SCHEMBL13521974; CC0179; 1,3-Di(3-methoxy-4-hydroxystyryl)propanedial; Terra Merita; NCGC00258668-01; SBB006495; Curcumin, matrix substance for MALDI-MS, >=99.5% (HPLC); STL371943; AN-23454; CURCUMIN (SEE ALSO TUMERIC, OLEORESIN (10105-J)); 8024-37-1; Curcuma longa oils; 91884-86-5; AKOS001305497; BRD-K07572174-001-02-2; Turmeric extract; TURMERIC, OLEORESIN (CURCUMIN) (SEE ALSO CURCURMIN (458-37-7)); CI Natural Yellow 3; Cucurmin; CHEBI:3962; DTXSID8031077; DB-002681; Curcumine; Turmeric root oleoresin; curcumin; turmeric root oil CO2 extract; Curcumin, from Curcuma longa (Turmeric), powder; NCGC00017159-12; 79257-48-0; C.I. 75300; 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadien-3,5-dione; NSC 32982; SR-01000000149-5, curcumine;curcumin | IC21H20O6 | 368.4 g/mol | COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O |
疾病对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE001554 | KCNK4 | FHEIG; K2p4.1; TRAAK; TRAAK1 | potassium two pore domain channel subfamily K member 4 |
| TCMBANKGE006560 | VPS13B | CHS1; COH1 | vacuolar protein sorting 13 homolog B |
| TCMBANKGE003578 | RARA | NR1B1; RAR | retinoic acid receptor alpha |
| TCMBANKGE003804 | FGFR2 | BBDS; BEK; BFR-1; CD332; CEK3; CFD1; ECT1; JWS; K-SAM; KGFR; TK14; TK25 | fibroblast growth factor receptor 2 |
| TCMBANKGE001652 | ABCA5 | ABC13; EST90625; HTC3 | ATP binding cassette subfamily A member 5 |
| TCMBANKGE002518 | TBCK | HSPC302; IHPRF3; TBCKL | TBC1 domain containing kinase |
| TCMBANKGE002746 | PIGN | MCAHS; MCAHS1; MCD4; MDC4; PIG-N | phosphatidylinositol glycan anchor biosynthesis class N |
| TCMBANKGE000023 | CNTNAP1 | CASPR; CHN3; CNTNAP; NRXN4; P190 | contactin associated protein 1 |
| TCMBANKGE007917 | IDUA | IDA; MPS1; MPSI | alpha-L-iduronidase |
| TCMBANKGE012867 | AGA | AGU; ASRG; GA | aspartylglucosaminidase |
| TCMBANKGE009869 | GNAQ | CMC1; G-ALPHA-q; GAQ; SWS | G protein subunit alpha q |
| TCMBANKGE012728 | SH3PXD2B | FAD49; FTHS; HOFI; KIAA1295; TKS4; TSK4 | SH3 and PX domains 2B |
| TCMBANKGE010711 | ABCC9 | ABC37; ATFB12; CANTU; CMD1O; SUR2 | ATP binding cassette subfamily C member 9 |
| TCMBANKGE003359 | TBC1D24 | DFNA65; DFNB86; DOORS; EIEE16; EPRPDC; FIME; TLDC6 | TBC1 domain family member 24 |
| TCMBANKGE013010 | COX2 | COII; MTCO2 | cytochrome c oxidase subunit II |
| TCMBANKGE011458 | CLIP2 | CLIP; CLIP-115; CYLN2; WBSCR3; WBSCR4; WSCR3; WSCR4 | CAP-Gly domain containing linker protein 2 |
| TCMBANKGE009636 | MGAT2 | CDG2A; CDGS2; GLCNACTII; GNT-II; GNT2 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
| TCMBANKGE002175 | COL3A1 | EDS4A; EDSVASC; PMGEDSV | collagen type III alpha 1 chain |
| TCMBANKGE005031 | RIN2 | MACS; RASSF4 | Ras and Rab interactor 2 |
| TCMBANKGE004515 | NXN | NRX; RRS2; TRG-4 | nucleoredoxin |
| TCMBANKGE005562 | USP9X | DFFRX; FAF; FAM; MRX99; MRXS99F | ubiquitin specific peptidase 9 X-linked |
| TCMBANKGE005872 | ROR2 | BDB; BDB1; NTRKR2 | receptor tyrosine kinase like orphan receptor 2 |
| TCMBANKGE006257 | OSTM1 | GIPN; GL; HSPC019; OPTB5 | osteoclastogenesis associated transmembrane protein 1 |
| TCMBANKGE006278 | PLAGL1 | LOT1; ZAC; ZAC1 | PLAG1 like zinc finger 1 |
| TCMBANKGE000282 | ELN | ADCL1; SVAS; WBS; WS | elastin |
| TCMBANKGE010273 | REST | DFNA27; GINGF5; HGF5; NRSF; WT6; XBR | RE1 silencing transcription factor |
| TCMBANKGE001257 | RET | CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET-ELE1 | ret proto-oncogene |
| TCMBANKGE000033 | SOS1 | GF1; GGF1; GINGF; HGF; NS4; SOS-1 | SOS Ras/Rac guanine nucleotide exchange factor 1 |
| TCMBANKGE005302 | DVL1 | DRS2; DVL; DVL1L1; DVL1P1 | dishevelled segment polarity protein 1 |
| TCMBANKGE001037 | MMP2 | CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1 | matrix metallopeptidase 2 |
| TCMBANKGE005249 | ATP6V1B2 | ATP6B1B2; ATP6B2; DOOD; HO57; VATB; VPP3; Vma2; ZLS2 | ATPase H+ transporting V1 subunit B2 |
| TCMBANKGE007361 | C1R | EDSPD1 | complement C1r |
| TCMBANKGE001091 | ND5 | MTND5 | NADH dehydrogenase, subunit 5 (complex I) |
| TCMBANKGE001178 | STAT3 | ADMIO; ADMIO1; APRF; HIES | signal transducer and activator of transcription 3 |
| TCMBANKGE004181 | GLB1 | EBP; ELNR1; MPS4B | galactosidase beta 1 |
| TCMBANKGE005741 | ZBTB16 | PLZF; ZNF145 | zinc finger and BTB domain containing 16 |
| TCMBANKGE006400 | PLG | - | plasminogen |
| TCMBANKGE003705 | EMC1 | CAVIPMR; KIAA0090 | ER membrane protein complex subunit 1 |
| TCMBANKGE000652 | STAT5B | STAT5 | signal transducer and activator of transcription 5B |
| TCMBANKGE008442 | NFIX | CTF; MRSHSS; NF-I/X; NF1-X; NF1A; SOTOS2 | nuclear factor I X |
| TCMBANKGE007340 | SC5D | ERG3; S5DES; SC5DL | sterol-C5-desaturase |
| TCMBANKGE005541 | GTF2IRD1 | BEN; CREAM1; GTF3; MUSTRD1; RBAP2; WBS; WBSCR11; WBSCR12; hMusTRD1alpha1 | GTF2I repeat domain containing 1 |
| TCMBANKGE010892 | CCBE1 | HKLLS1 | collagen and calcium binding EGF domains 1 |
| TCMBANKGE010469 | C1S | EDSPD2 | complement C1s |
| TCMBANKGE008826 | LBR | C14SR; DHCR14B; LMN2R; PHA; PHASK; TDRD18 | lamin B receptor |
| TCMBANKGE010446 | NUMA1 | NMP-22; NUMA | nuclear mitotic apparatus protein 1 |
| TCMBANKGE007130 | BCOR | ANOP2; MAA2; MCOPS2 | BCL6 corepressor |
| TCMBANKGE007431 | RFC2 | RFC40 | replication factor C subunit 2 |
| TCMBANKGE004793 | WNT5A | hWNT5A | Wnt family member 5A |
| TCMBANKGE007164 | MAN2B1 | LAMAN; MANB | mannosidase alpha class 2B member 1 |
| TCMBANKGE011372 | ANTXR2 | CMG-2; CMG2; HFS; ISH; JHF | ANTXR cell adhesion molecule 2 |
| TCMBANKGE009748 | BAZ1B | WBSCR10; WBSCR9; WSTF | bromodomain adjacent to zinc finger domain 1B |
| TCMBANKGE010995 | GUSB | BG; MPS7 | glucuronidase beta |
| TCMBANKGE000063 | SCN8A | BFIS5; CERIII; CIAT; EIEE13; MED; MYOCL2; NaCh6; Nav1.6; PN4 | sodium voltage-gated channel alpha subunit 8 |
| TCMBANKGE011805 | KCNH1 | EAG; EAG1; Kv10.1; TMBTS; ZLS1; h-eag; hEAG; hEAG1 | potassium voltage-gated channel subfamily H member 1 |
| TCMBANKGE007543 | INSR | CD220; HHF5 | insulin receptor |
| TCMBANKGE000846 | MMP14 | MMP-14; MMP-X1; MT-MMP; MT-MMP 1; MT1-MMP; MT1MMP; MTMMP1; WNCHRS | matrix metallopeptidase 14 |
| TCMBANKGE007024 | SLC29A3 | ENT3; HCLAP; HJCD; PHID | solute carrier family 29 member 3 |
| TCMBANKGE012330 | LIMK1 | LIMK; LIMK-1 | LIM domain kinase 1 |
| TCMBANKGE011723 | DHCR7 | SLOS | 7-dehydrocholesterol reductase |
| TCMBANKGE006189 | FAM20A | AI1G; AIGFS; FP2747 | FAM20A golgi associated secretory pathway pseudokinase |
| TCMBANKGE001223 | SLC17A5 | AST; ISSD; NSD; SD; SIALIN; SIASD; SLD | solute carrier family 17 member 5 |
| TCMBANKGE000688 | AIMP2 | HLD17; JTV-1; JTV1; P38 | aminoacyl tRNA synthetase complex interacting multifunctional protein 2 |
| TCMBANKGE001672 | FGF3 | HBGF-3; INT2 | fibroblast growth factor 3 |
| TCMBANKGE000459 | PRKAR1A | ACRDYS1; ADOHR; CAR; CNC; CNC1; PKR1; PPNAD1; PRKAR1; TSE1 | protein kinase cAMP-dependent type I regulatory subunit alpha |
| TCMBANKGE011881 | NPM1 | B23; NPM | nucleophosmin 1 |
| TCMBANKGE010998 | TBL1XR1 | C21; DC42; IRA1; MRD41; TBLR1 | TBL1X receptor 1 |
| TCMBANKGE006492 | IRF2BP2 | CVID14 | interferon regulatory factor 2 binding protein 2 |
| TCMBANKGE000350 | PML | MYL; PP8675; RNF71; TRIM19 | PML nuclear body scaffold |
| TCMBANKGE011951 | KIF1A | ATSV; C2orf20; HSN2C; MRD9; NESCAVS; SPG30; UNC104 | kinesin family member 1A |
| TCMBANKGE009351 | FZD2 | Fz2; OMOD2; fz-2; fzE2; hFz2 | frizzled class receptor 2 |
| TCMBANKGE013330 | FAT4 | CDHF14; CDHR11; FAT-J; FATJ; HKLLS2; NBLA00548; VMLDS2 | FAT atypical cadherin 4 |
| TCMBANKGE005887 | FAM20C | DMP-4; DMP4; G-CK; GEF-CK; RNS | FAM20C golgi associated secretory pathway kinase |
| TCMBANKGE013917 | ADAMTS3 | ADAMTS-4; HKLLS3 | ADAM metallopeptidase with thrombospondin type 1 motif 3 |
| TCMBANKGE009354 | PIGA | GPI3; MCAHS2; PIG-A; PNH1 | phosphatidylinositol glycan anchor biosynthesis class A |
滇IICP备16009434号-1 |
Dai SX Lab